| GlaxoSmithKline AG - Cervarix, Suspension zur i.m. Injektion | | 57814 | | 01 | | Cervarix | | Suspension zur i.m. Injektion | | J07BM02 | | Papillomavirus (Human Types 16, 18) | | 04.03.2010 | | |
| | Composition | | proteinum L1 papillomaviri humani typus 16 20 µg, proteinum L1 papillomaviri humani typus 18 20 µg, Adeps A 3-O-desacyl-4’-monophosphorylatus, aluminium ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum, natrii dihydrogenophosphas dihydricus, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.82 mg. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
